Kecskemeti V - Search Results

1

Bagdy G, Kecskemeti V, Riba P, Jakus R. Bagdy G, et al. Among authors: kecskemeti v. J Neurochem. 2007 Feb;100(4):857-73. doi: 10.1111/j.1471-4159.2006.04277.x. Epub 2007 Jan 24. J Neurochem. 2007. PMID: 17212700 Free article. Review.

2

Headache-type adverse effects of NO donors: vasodilation and beyond.

Bagdy G, Riba P, Kecskeméti V, Chase D, Juhász G. Bagdy G, et al. Among authors: kecskemeti v. Br J Pharmacol. 2010 May;160(1):20-35. doi: 10.1111/j.1476-5381.2010.00643.x. Epub 2010 Mar 19. Br J Pharmacol. 2010. PMID: 20331608 Free PMC article. Review.

3

Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies.

Kecskeméti V, Rusznák Z, Riba P, Pál B, Wagner R, Harasztosi C, Nánási PP, Szûcs G. Kecskeméti V, et al. Brain Res Bull. 2005 Sep 30;67(1-2):126-32. doi: 10.1016/j.brainresbull.2005.06.027. Brain Res Bull. 2005. PMID: 16140171

4

Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.

Pacher P, Ungvari Z, Kecskemeti V, Furst S. Pacher P, et al. Among authors: kecskemeti v. Curr Med Chem. 1998 Oct;5(5):381-90. Curr Med Chem. 1998. PMID: 9756980 Review.

5

Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity.

Pacher P, Ungvari Z, Kecskemeti V, Koller A. Pacher P, et al. Among authors: kecskemeti v. Br J Pharmacol. 1999 Jun;127(3):740-6. doi: 10.1038/sj.bjp.0702571. Br J Pharmacol. 1999. PMID: 10401565 Free PMC article.

6

Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?

Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V. Pacher P, et al. Among authors: kecskemeti v. Curr Med Chem. 1999 Jun;6(6):469-80. Curr Med Chem. 1999. PMID: 10213794 Review.

7

Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener.

Ungvari Z, Pacher P, Kecskeméti V, Koller A. Ungvari Z, et al. Among authors: kecskemeti v. Stroke. 1999 Sep;30(9):1949-54. doi: 10.1161/01.str.30.9.1949. Stroke. 1999. PMID: 10471449

8

Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle.

Pacher P, Ungvari Z, Kecskeméti V, Friedmann T, Furst S. Pacher P, et al. Among authors: kecskemeti v. Can J Physiol Pharmacol. 2001 Jul;79(7):580-4. Can J Physiol Pharmacol. 2001. PMID: 11478591

9

New trends in the development of oral antidiabetic drugs.

Kecskemeti V, Bagi Z, Pacher P, Posa I, Kocsis E, Koltai MZ. Kecskemeti V, et al. Curr Med Chem. 2002 Jan;9(1):53-71. doi: 10.2174/0929867023371427. Curr Med Chem. 2002. PMID: 11860348 Review.

10

Molecular action of class I antiarrhythmic drugs and clinical implications.

Kecskemeti V. Kecskemeti V. Pharmacol Res. 1991 Aug;24(2):131-42. doi: 10.1016/1043-6618(91)90028-v. Pharmacol Res. 1991. PMID: 1749744 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters